{"id":"https://openalex.org/W4308385281","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0715","title":"715 Emerging results from the use of an oncolytic adenovirus armed with TNFa and IL-2 (TILT-123) in different phase I solid tumor clinical trials","display_name":"715 Emerging results from the use of an oncolytic adenovirus armed with TNFa and IL-2 (TILT-123) in different phase I solid tumor clinical trials","publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4308385281","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0715"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2022-sitc2022.0715","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0715","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0715","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A748.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A748.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080358452","display_name":"V\u00edctor Cervera-Carrasc\u00f3n","orcid":"https://orcid.org/0000-0001-6684-3666","observed_orcids":["https://orcid.org/0000-0001-6684-3666"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victor Cervera-Carrascon","raw_affiliation_strings":["TILT Biotherapeutics Ltd, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TILT Biotherapeutics Ltd, Helsinki, Finland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051043977","display_name":"Inge Marie Svane","orcid":"https://orcid.org/0000-0002-9451-6037","observed_orcids":["https://orcid.org/0000-0002-9451-6037","https://orcid.org/0000-0002-0930-8541"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Inge Svane","raw_affiliation_strings":["CCIT, Herlev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CCIT, Herlev, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011563007","display_name":"Katriina Johanna Peltola","orcid":"https://orcid.org/0000-0002-3007-193X","observed_orcids":["https://orcid.org/0000-0002-3007-193X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katriina Peltola","raw_affiliation_strings":["Comprehensive Cancer Centre, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Centre, Helsinki, Finland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065474301","display_name":"Tuomo Alanko","orcid":"https://orcid.org/0000-0002-1649-9040","observed_orcids":["https://orcid.org/0000-0002-1649-9040"]},"institutions":[{"id":"https://openalex.org/I4210165436","display_name":"Docrates Cancer Center","ror":"https://ror.org/05gdz0e37","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I4210165436"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Tuomo Alanko","raw_affiliation_strings":["Docrates Cancer Centre, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Docrates Cancer Centre, Helsinki, Finland","institution_ids":["https://openalex.org/I4210165436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007169190","display_name":"Riitta Korpisaari","orcid":"https://orcid.org/0009-0000-9924-1629","observed_orcids":["https://orcid.org/0009-0000-9924-1629"]},"institutions":[{"id":"https://openalex.org/I4210165436","display_name":"Docrates Cancer Center","ror":"https://ror.org/05gdz0e37","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I4210165436"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Riitta Korpisaari","raw_affiliation_strings":["Docrates Cancer Centre, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Docrates Cancer Centre, Helsinki, Finland","institution_ids":["https://openalex.org/I4210165436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019145336","display_name":"Susanna Juteau","orcid":"https://orcid.org/0000-0001-9321-2093","observed_orcids":["https://orcid.org/0000-0001-9321-2093"]},"institutions":[{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Susanna Juteau","raw_affiliation_strings":["Helsinki University Hospital, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helsinki University Hospital, Helsinki, Finland","institution_ids":["https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111313363","display_name":"Marjut Jaakkola","orcid":"https://orcid.org/0000-0003-1709-3138","observed_orcids":["https://orcid.org/0000-0003-1709-3138"]},"institutions":[{"id":"https://openalex.org/I4210165436","display_name":"Docrates Cancer Center","ror":"https://ror.org/05gdz0e37","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I4210165436"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Marjut Jaakkola","raw_affiliation_strings":["Docrates Cancer Centre, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Docrates Cancer Centre, Helsinki, Finland","institution_ids":["https://openalex.org/I4210165436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024539974","display_name":"Jorma Sormunen","orcid":"https://orcid.org/0000-0002-1992-1251","observed_orcids":["https://orcid.org/0000-0002-1992-1251"]},"institutions":[{"id":"https://openalex.org/I4210165436","display_name":"Docrates Cancer Center","ror":"https://ror.org/05gdz0e37","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I4210165436"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Jorma Sormunen","raw_affiliation_strings":["Docrates Cancer Centre, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Docrates Cancer Centre, Helsinki, Finland","institution_ids":["https://openalex.org/I4210165436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062191415","display_name":"Juha Kononen","orcid":"https://orcid.org/0000-0002-0157-2137","observed_orcids":["https://orcid.org/0000-0002-0157-2137"]},"institutions":[{"id":"https://openalex.org/I4210165436","display_name":"Docrates Cancer Center","ror":"https://ror.org/05gdz0e37","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I4210165436"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Juha Kononen","raw_affiliation_strings":["Docrates Cancer Centre, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Docrates Cancer Centre, Helsinki, Finland","institution_ids":["https://openalex.org/I4210165436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031370633","display_name":"Eva Elleb\u00e6k","orcid":"https://orcid.org/0000-0001-6748-9232","observed_orcids":["https://orcid.org/0000-0001-6748-9232"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eva Ellebaek Steensgaard","raw_affiliation_strings":["CCIT, Herlev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CCIT, Herlev, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036808328","display_name":"Tine Juul Monberg","orcid":"https://orcid.org/0000-0002-7217-2974","observed_orcids":["https://orcid.org/0000-0002-7217-2974"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tine Monberg","raw_affiliation_strings":["CCIT, Herlev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CCIT, Herlev, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025825017","display_name":"Marco Donia","orcid":"https://orcid.org/0000-0003-4966-9752","observed_orcids":["https://orcid.org/0000-0003-4966-9752"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marco Donia","raw_affiliation_strings":["CCIT, Herlev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CCIT, Herlev, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001247907","display_name":"Amir Khammari","orcid":"https://orcid.org/0000-0001-9328-8004","observed_orcids":["https://orcid.org/0000-0001-9328-8004"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]},{"id":"https://openalex.org/I4210092509","display_name":"Centre de Recherche en Canc\u00e9rologie et Immunologie Int\u00e9gr\u00e9e Nantes Angers","ror":"https://ror.org/003g1aw90","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I3019204325","https://openalex.org/I4210092509","https://openalex.org/I4210096427","https://openalex.org/I4210106090","https://openalex.org/I4210112910","https://openalex.org/I49451733","https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Amir Khammari","raw_affiliation_strings":["CRCINA Inserm, CHU Nantes, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRCINA Inserm, CHU Nantes, Nantes, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I3019204325","https://openalex.org/I4210092509"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002644565","display_name":"Brigitte Dr\u00e9no","orcid":"https://orcid.org/0000-0001-5574-5825","observed_orcids":["https://orcid.org/0000-0001-5574-5825"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]},{"id":"https://openalex.org/I4210092509","display_name":"Centre de Recherche en Canc\u00e9rologie et Immunologie Int\u00e9gr\u00e9e Nantes Angers","ror":"https://ror.org/003g1aw90","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I3019204325","https://openalex.org/I4210092509","https://openalex.org/I4210096427","https://openalex.org/I4210106090","https://openalex.org/I4210112910","https://openalex.org/I49451733","https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Brigitte Dreno","raw_affiliation_strings":["CRCINA Inserm, CHU Nantes, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRCINA Inserm, CHU Nantes, Nantes, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I3019204325","https://openalex.org/I4210092509"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109591000","display_name":"Joao Santos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joao Santos","raw_affiliation_strings":["TILT Biotherapeutics Ltd, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TILT Biotherapeutics Ltd, Helsinki, Finland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062608835","display_name":"Suvi Sorsa","orcid":"https://orcid.org/0009-0002-1709-611X","observed_orcids":["https://orcid.org/0009-0002-1709-611X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suvi Sorsa","raw_affiliation_strings":["TILT Biotherapeutics Ltd, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TILT Biotherapeutics Ltd, Helsinki, Finland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029723342","display_name":"Riikka Havunen","orcid":"https://orcid.org/0009-0008-7926-5285","observed_orcids":["https://orcid.org/0009-0008-7926-5285"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Riikka Havunen","raw_affiliation_strings":["TILT Biotherapeutics Ltd, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TILT Biotherapeutics Ltd, Helsinki, Finland","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062078543","display_name":"Akseli Hemminki","orcid":"https://orcid.org/0000-0001-7103-8530","observed_orcids":["https://orcid.org/0000-0001-7103-8530"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akseli Hemminki","raw_affiliation_strings":["TILT Biotherapeutics Ltd, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TILT Biotherapeutics Ltd, Helsinki, Finland","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A748","last_page":"A748"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.013000000268220901,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.008500000461935997,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncolytic-adenovirus","display_name":"oncolytic adenovirus","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.8899999856948853},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.9549999833106995},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7990000247955322},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.4779999852180481},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.8109999895095825},{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.7360000014305115},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9919999837875366},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9829999804496765},{"id":"https://openalex.org/keywords/tumor-immunogenicity","display_name":"tumor immunogenicity","score":0.4410000145435333},{"id":"https://openalex.org/keywords/cancer-proteomics","display_name":"cancer proteomics","score":0.367000013589859},{"id":"https://openalex.org/keywords/cancer-transcriptomics","display_name":"cancer transcriptomics","score":0.847000002861023},{"id":"https://openalex.org/keywords/viral-persistence","display_name":"viral persistence","score":0.5350000262260437},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5580000281333923},{"id":"https://openalex.org/keywords/refractory-cancer","display_name":"refractory cancer","score":0.6729999780654907},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6840000152587891}],"concepts":[{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.8118460774421692},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7602912187576294},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.7059938907623291},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6511282920837402},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6155576109886169},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.594438374042511},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5484191179275513},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5408113598823547},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5352230072021484},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46643996238708496},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4501941502094269}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2022-sitc2022.0715","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0715","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0715","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A748.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2022-sitc2022.0715","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0715","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0715","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A748.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310086","display_name":"Helsingin Yliopisto","ror":"https://ror.org/040af2s02"},{"id":"https://openalex.org/F4320312902","display_name":"Society for Immunotherapy of Cancer","ror":"https://ror.org/0481e3r23"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4308385281.pdf","grobid_xml":"https://content.openalex.org/works/W4308385281.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388084089","https://openalex.org/W4388083083","https://openalex.org/W4393259648","https://openalex.org/W3203317065","https://openalex.org/W4286294566","https://openalex.org/W4400530074","https://openalex.org/W7199151683","https://openalex.org/W4388048444","https://openalex.org/W3122662118","https://openalex.org/W2994705166"],"abstract_inverted_index":{"Background":[0],"After":[1,98],"the":[2,15,32,36,39,86,90,103,156,163,187,205,210,222,236,278,310,331,334,343,348,352,409,413,417,430,464,482,500,518],"first":[3],"Immune":[4],"Checkpoint":[5],"Inhibitor":[6],"(ICI)":[7],"was":[8,82,105,461,479,497,515],"approved":[9,462,480,498,516],"(ipilimumab,":[10],"2011":[11],"for":[12,440],"cancer":[13,30,60],"therapy,":[14],"list":[16],"of":[17,29,35,50,54,96,159,162,189,209,226,333,387,419,436,438],"indications":[18],"routinely":[19],"treated":[20,178,266],"with":[21,78,135,167,179,267],"ICIs":[22,144],"keeps":[23],"increasing.":[24],"In":[25],"this":[26,424],"new":[27],"era":[28],"immunotherapy,":[31],"major":[33],"drawback":[34],"approach":[37,370],"is":[38,124,183],"difficulty":[40],"in":[41,57,66,110,165,228,242,256,324,380,385,393,423],"delivering":[42],"long":[43],"term":[44],"benefits":[45],"to":[46,63,84,92,127,204,249,273,309,317,366,372,391,408,421,429],"a":[47,388],"larger":[48],"portion":[49],"patients.":[51,258,326],"Different":[52],"forms":[53,95],"immunotherapy":[55],"used":[56],"solid":[58,173],"tumor":[59,91,335],"patients":[61,166,265,420],"seem":[62],"work":[64],"better":[65],"immunologically":[67],"hot":[68],"tumors.":[69],"To":[70],"that":[71,175],"extent,":[72],"TILT-123":[73,123,268],"(an":[74],"Oncolytic":[75],"Adenovirus":[76],"armed":[77],"TNFa":[79],"and":[80,100,143,171,196,212,224,231,238,303,347,379,416,454],"IL-2)":[81],"designed":[83],"stimulate":[85],"immune":[87,349],"system":[88],"within":[89,351],"enable":[93],"subsequent":[94],"immunotherapy.":[97],"discovery":[99],"preclinical":[101],"testing,":[102],"therapy":[104,138],"taken":[106],"into":[107],"clinical":[108,118,153,361,396,400],"trials":[109,119,206,362,401],"2020.":[111],"Two":[112],"years":[113],"after,":[114],"four":[115],"Phase":[116,359,394],"I":[117,150,360],"are":[120,427],"ongoing":[121],"where":[122],"being":[125],"tested":[126],"determine":[128],"its":[129],"safety":[130,161,197,261],"as":[131,233,277,295,377],"monotherapy":[132,378],"(NCT04695327),":[133],"together":[134],"adoptive":[136],"cell":[137,345],"using":[139,363],"tumor-infiltrating":[140],"lymphocytes":[141],"(NCT04217473),":[142],"(NCT05271318,":[145],"NCT05222932).":[146],"Methods":[147],"These":[148],"phase":[149],"open-label,":[151],"dose-escalation":[152],"trials,":[154],"have":[155],"primary":[157],"endpoint":[158],"establishing":[160],"treatments":[164],"injectable":[168],"advanced":[169],"refractory":[170],"recurrent":[172],"tumors,":[174],"cannot":[176],"be":[177],"curative":[180],"intent.":[181],"Safety":[182],"evaluated":[184],"based":[185,215],"on":[186,193,216,221,468,486,504,522],"occurrence":[188],"adverse":[190,293],"events,":[191,294],"impact":[192],"vital":[194],"signs":[195],"laboratory":[198],"tests.":[199],"Additionally,":[200],"secondary":[201],"endpoints":[202],"relative":[203],"include":[207],"efficacy":[208,315],"approaches":[211],"mechanistic":[213],"analyses":[214,329],"biological":[217],"samples,":[218],"including":[219],"studies":[220],"presence":[223,346],"persistence":[225],"virus":[227],"different":[229,257],"fluids":[230],"tissues,":[232],"well":[234],"as,":[235],"proteomic":[237],"transcriptomic":[239],"changes":[240],"seen":[241,323],"tumors":[243],"after":[244],"therapy.":[245],"Antitumor":[246],"efficacy,":[247],"according":[248,308,316],"RECIST":[250,318],"1.1/iRECIST/PET":[251,319],"criteria,":[252],"has":[253,321],"been":[254,322],"recorded":[255],"Results":[259],"Interim":[260],"data":[262,356],"emerging":[263,357],"from":[264,358,412],"(n=18":[269],"patients),":[270],"provided":[271],"confidence":[272],"continue":[274],"dose":[275,285,390],"escalation":[276,383],"investigational":[279],"medicinal":[280],"product":[281],"did":[282],"not":[283],"cause":[284],"limiting":[286],"toxicities.":[287],"The":[288,399],"most":[289],"frequent":[290],"treatment":[291],"related":[292],"judged":[296],"by":[297,445,463,481,499,517],"investigators,":[298],"were":[299,404],"fever,":[300],"nausea,":[301],"chills":[302],"fatigue,":[304],"typically":[305],"low":[306],"grade":[307],"CTCAE":[311],"v5.0.":[312],"Systemic":[313],"antitumor":[314,339,374],"criteria":[320],"several":[325],"Biological":[327],"sample":[328],"demonstrate":[330],"remodeling":[332],"microenvironment":[336],"towards":[337],"an":[338,367],"status,":[340],"when":[341],"studying":[342],"T":[344],"signature":[350],"tumor.":[353],"Conclusions":[354],"Preliminary":[355],"TILT-123,":[364],"point":[365],"adequately":[368],"safe":[369],"able":[371],"induce":[373],"activity,":[375],"both":[376],"combination.":[381],"Dose":[382],"continues":[384],"pursuit":[386],"recommended":[389],"use":[392],"II":[395],"trials.":[397],"Acknowledgements":[398],"reported":[402],"above":[403],"made":[405],"possible":[406],"due":[407],"magnificent":[410],"teamwork":[411],"trial":[414],"sites":[415],"willingness":[418],"collaborate":[422],"research.":[425],"Authors":[426],"thankful":[428],"entire":[431],"Cancer":[432],"Gene":[433],"Therapy":[434],"Group":[435],"University":[437],"Helsinki":[439],"their":[441],"valuable":[442],"support.":[443],"Funded":[444],"TILT":[446],"Biotherapeutics":[447],"Ltd.":[448],"Trial":[449],"Registration":[450],"NCT04695327,":[451],"NCT04217473,":[452],"NCT05271318,":[453],"NCT05222932":[455],"Ethics":[456,471,489,507,525],"Approval":[457],"TILT-T115:":[458],"This":[459,477,495,513],"study":[460,478,496,514],"Finnish":[465,501,519],"National":[466,484,502,520],"Committee":[467,485,503,521],"Medical":[469,505,523],"Research":[470,488,506,524],"(TUKIJA);":[472,508,526],"approval":[473,491,509,527],"number":[474,492,510,528],"HUS/1804/2020":[475],"TILT-T215:":[476],"Danish":[483],"Health":[487],"(NVK);":[490],"1905760":[493],"TILT-T563:":[494],"TUKIJA/405/2021":[511],"TILT-T776:":[512],"TUKIJA/366/2021":[529]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2022-11-11T00:00:00"}